Characterization of the antimonial antileishmanial agent meglumine antimonate (Glucantime)

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 5, 1998, Pages 1076-1082

  Roberts, William L ^a   Mcmurray, Walter J ^b,c   Rainey, Petrie M ^c  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILEISHMANIAL AGENT; ANTIMONY; MEGLUMINE; MEGLUMINE ANTIMONATE; STIBOGLUCONATE SODIUM;

ANTIPROTOZOAL ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; FAST ATOM BOMBARDMENT MASS SPECTROMETRY; MOLECULAR WEIGHT; OSMOLALITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 0031971089     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.5.1076     Document Type: Article

References (13)

1. Angel, A.-S., and B. Nilsson. 1990. Linkage positions in glycoconjugates by periodate oxidation and fast atom bombardment mass spectrometry. Methods Enzymol. 193:587-607.
2. Berman, J. D., and M. Grogl. 1988. Leishmania mexicana: chemistry and biochemistry of sodium stibogluconate (Pentostam). Exp. Parasitol. 67:96-103.
3. Doak, G. O., and L. D. Freedman. 1960. Organometallic compounds of arsenic, antimony and bismuth, p. 291. Wiley-Interscience, New York, N.Y.
4. Headley, J. V., M. S. Yong, P. W. Brooks, and A. Phillips. 1995. Fast-atom bombardment mass spectrometry of the organometallic parasiticide, meglumine antimonate. Rapid Commun. Mass Spectrom. 9:372-376.
5. Lide, D. R. (ed.) 1996. CRC handbook of chemistry and physics, 77th ed., p. 4-41. CRC Press, New York, N.Y.
6. Masamori, E., A. Benitez, and P. Lim. 1986. Assay of sodium stibogluconate (Pentostam). Report no. 552; contract no. DAMD17-85-C-5141. United States Army Medical Research and Development Command, Office of the Surgeon General, Washington, D.C.
7. Roberts, W. L., and P. M. Rainey. 1993. Antimony quantification in Leishmania by electrothermal atomic absorption spectroscopy. Anal. Biochem. 211:1-6.
8. Roberts, W. L., and P. M. Rainey. 1993. Antileishmanial activity of sodium stibogluconate fractions. Antimicrob. Agents Chemother. 37:1842-1846.
9. Steck, E. A. 1974. The leishmaniases. Prog. Drug Res. 18:289-351.
10. Tapscott, R. E., R. L. Belford, and I. C. Paul. 1969. Stereochemistry of tartrato(4-)-bridged binuclear complexes. Coord. Chem. Rev. 4:323-359.
11. Tracy, J. W., and L. T. Webster. 1996. Chemotherapy of parasitic infections, p. 987-1008. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman (ed.), Goodman & Gilman's the pharmacological basis of therapeutics, 9th ed. McGraw-Hill Book Co., New York, N.Y.
12. Watnick, P. I., and P. M. Rainey. Unpublished data.
13. World Health Organization. 1990. Control of the leishmaniases, p. 9-15. Report of a WHO expert committee. World Health Organization Technical Report Services Report no. 793. World Health Organization, Geneva, Switzerland.